Published time:2017-12-01
Document type:PDF
Language version:English/Chinese
Published by AskCI
No. | Content | Page |
---|---|---|
Executive Summary | ||
Methodology | ||
1 | Overview of Probiotics Industry in the Globe | |
1.1 | Current Development | |
1.2 | Market Scale of Probiotic Products | |
1.3 | Consumption Structure of Probiotics in the Globe | |
2 | Overview of Probiotics Industry in China | |
2.1 | Current Development | |
2.1.1 | Major Brands in Probiotics Industry | |
2.1.2 | Current Market Demand in Probiotics Industry | |
2.1.3 | Analysis on Market Trend for Probiotics in China | |
2.2 | Regulation and Policy | |
2.3 | Technology Analysis | |
2.4 | Analysis on Probiotics Industry Prospects | |
2.4.1 | Market Analysis on Prospects of Probiotic Products | |
2.4.1 | Market Analysis on Prospects of Probiotic Powder | |
2.5 | Supply and Demand | |
2.5.1 | Analysis on Probiotics Consumption | |
2.5.2 | Analysis on Market Scale of Probiotic Products | |
2.5.3 | Demand Structure of Probiotics Market | |
3 | Industrial Chain of Probiotics Industry in China | |
3.1 | Upstream Analysis | |
3.2 | Downstream Analysis | |
3.2.1 | Analysis on Yogurt Industry | |
3.2.2 | Analysis on Milk Beverage Industry | |
3.2.3 | Analysis on Fruits and Vegetables Juice Industry | |
3.2.4 | Analysis on Health-Care Foods Industry | |
3.2.5 | Analysis on Pharmaceuticals Industry | |
3.2.6 | Analysis on Infant Milk Powder Industry | |
3.2.7 | Analysis on Cosmetics Industry | |
3.2.8 | Analysis on Feed Industry | |
4 | Key Players of Probiotics Industry Overseas | |
4.1 | Chr. Hansen Holding A/S | |
4.1.1 | Basic Information of Enterprise Development | |
4.1.2 | Analysis on Probiotic Products of Chr. Hansen | |
4.1.3 | Analysis on Operating Condition | |
4.1.4 | Analysis on Development of Chr. Hansen in China | |
4.2 | Valio Ltd. | |
4.2.1 | Basic Information of Enterprise Development | |
4.2.2 | Analysis on Major Products | |
4.2.4 | Analysis on Investment Program of Valio in China | |
4.3 | France H.C.S. Group Ltd. | |
4.3.1 | Basic Information of Enterprise Development | |
4.3.2 | Analysis on Major Products | |
4.3.3 | Analysis on Competitive Advantage | |
4.3.4 | Analysis on Investment Program of France H.C.S in China | |
4.4 | Yakult Honsha Co., Ltd. | |
4.4.1 | Basic Information of Enterprise Development | |
4.4.2 | Analysis on Major Products | |
4.4.3 | Analysis on Operating Condition | |
4.4.4 | Analysis on Investment Program of Yakult in China | |
4.5 | Royal DSM | |
4.5.1 | Basic Information of Enterprise Development | |
4.5.2 | Analysis on Its probiotic Products | |
4.5.3 | Analysis on Operating Condition | |
4.5.4 | Analysis on Development of DSM in China | |
4.6 | Other Enterprises | |
4.6.1 | DuPont | |
4.6.2 | Probi Ltd. | |
4.6.3 | Lallemand Group | |
5 | Key Players of Probiotics Industry in China | |
5.1 | Biostime Inc. Guangzhou | |
5.1.1 | Basic Information of Enterprise Development | |
5.1.2 | Analysis on Major Products | |
5.1.3 | Analysis on Operating Condition | |
5.1.4 | Analysis on Sale Network | |
5.1.5 | Analysis on Development Strategy of Biostime Group | |
5.2 | Shanghai Jiaoda Onlly Co., Ltd | |
5.2.1 | Basic Information of Enterprise Development | |
5.2.2 | Analysis on Major Products | |
5.2.3 | Analysis on Operating Condition | |
5.2.4 | Analysis on Sale Network | |
5.2.5 | Analysis on Development Strategy of Shanghai Jiaoda Onlly | |
5.3 | Kingworld Medicines Group Limited | |
5.3.1 | Basic Information of Enterprise Development | |
5.3.2 | Analysis on Major Products | |
5.3.3 | Analysis on Operating Condition | |
5.3.4 | Analysis on Sale Network | |
5.3.5 | Analysis on Development Strategy of Kingworld Medicines Group | |
5.4. | Sirio Pharma Co., Ltd. | |
5.4.1 | Basic Information of Enterprise Development | |
5.4.2 | Analysis on Major Products | |
5.4.3 | Analysis on Operating Condition | |
5.4.4 | Analysis on Sales Network | |
5.4.5 | Analysis on Development Strategy of Sirio Pharma | |
5.5 | Beijing Hanmi Pharmaceutical Co., Ltd. | |
5.5.1 | Basic Information of Enterprise Development | |
5.5.2 | Analysis on Major Products | |
5.5.3 | Analysis on Operating Condition | |
5.5.4 | Analysis on Enterprise Competitive Advantage | |
5.6 | Hanchenshi (Shenyang) Children's Products Co., Ltd. | |
5.6.1 | Basic Information of Enterprise Development | |
5.6.2 | Analysis on Major Products | |
5.6.3 | Analysis on Operating Condition | |
5.6.4 | Analysis on Enterprise Competitive Advantage | |
5.7 | Xiuzheng Pharmaceutical Group Co., Ltd. | |
5.7.1 | Basic Information of Enterprise Development | |
5.7.2 | Analysis on Major Products | |
5.7.3 | Analysis on Operating Condition | |
5.7.4 | Analysis on Enterprise Competitive Advantage | |
5.8 | Hangzhou Minsheng Pharmaceutical Group Co., Ltd. | |
5.8.1 | Basic Information of Enterprise Development | |
5.8.2 | Analysis on Major Products | |
5.8.3 | Analysis on Operating Condition | |
5.8.4 | Analysis on Enterprise Competitive Advantage | |
5.9 | Hutchison Healthcare Limited | |
5.9.1 | Basic Information of Enterprise Development | |
5.9.2 | Analysis on Major Products | |
5.9.3 | Analysis on Sales Network | |
5.9.4 | Analysis on Enterprise Competitive Advantage | |
5.10 | PT Solution Biotechnology Co., Ltd. | |
5.10.1 | Basic Information of Enterprise Development | |
5.10.2 | Analysis on Major Products | |
5.10.3 | Analysis on Operating Condition | |
5.10.4 | Analysis on Enterprise Competitive Advantage | |
5.11 | Harbin Meihua Biotechnology Co., Ltd. | |
5.11.1 | Basic Information of Enterprise Development | |
5.11.2 | Analysis on Major Products | |
5.11.3 | Analysis on Sales Network | |
6 | Prospect of Probiotics Industry in China | |
6.1 | Analysis on Prospect of Probiotics Industry in China | |
6.2 | Predicted Analysis on Market Scale of Probiotics Industry in China | |
7 | Conclusion and Recommendations | |
7.1 | Conclusion of Chinese Probiotics Industry | |
7.2 | Recommendations to Cultivate Market for Probiotics Industry in China | |
7.3 | Investment Strategy Recommendations to Probiotics Industry in China, 2017-2022 |
Figure No. | Figure Title |
---|---|
Figure 1 | Market scale of probiotic products in the globe, 2011-2016 |
Figure 2 | Consumption structure of probiotics in the globe |
Figure 3 | Market scale of probiotic products in China, 2011-2016 |
Figure 4 | Demand structure of probiotics market |
Figure 5 | Probiotics downstream products |
Figure 6 | The predicted retail market scale of domestic yoghurt in general in China, 2017-2022 |
Figure 7 | Numbers of enterprises at national scale in health-care foods industry in China, 2012-2016 |
Figure 8 | Assets scale of healthcare industry in China, 2011-2016 |
Figure 9 | The total sales revenue of health-care foods industry in China, 2011-2016 |
Figure 10 | The total profit of health-care foods industry in China, 2011-2016 |
Figure 11 | The numbers of pharmaceuticals manufacturers in China, 2011-2016 |
Figure 12 | Total value of assets in pharmaceuticals industry in China, 2011-2016 |
Figure 13 | Sales revenue of pharmaceuticals industry in China, 2011-2016 |
Figure 14 | Total profit of pharmaceuticals industry in China, 2011-2016 |
Figure 15 | The numbers of feed enterprises in China, 2011-2016 |
Figure 16 | Total value of assets in feed industry in China, 2011-2016 |
Figure 17 | Sales revenue of feed industry in China, 2011-2016 |
Figure 18 | The total profit of feed industry in China, 2011-2016 |
Figure 19 | Business structure of Guangzhou Biostime in 2017 |
Figure 20 | Business structure of Shanghai Jiaoda Onlly in 2017 |
Figure 21 | Business structure of Kingworld Medicines Group in 2017 |
Figure 22 | Business structure of Sirio Pharma in 2017 |
Figure 23 | Predicted market scale of probiotic products in China, 2017-2022 |
Table No. | Table Title |
---|---|
Table 1 | Ten major renowned brands and manufacturing enterprises of probiotics industry in China |
Table 2 | Laws and regulations on dairy industry |
Table 3 | List of bacterial species applicable to foods |
Table 4 | List of bacterial species applicable to infant foods |
Table 5 | Retail market scale of probiotic powder products in China, 2011-2016 |
Table 6 | Retailing market scale of children probiotic powder products in China, 2011-2016 |
Table 7 | Probiotics consumption in China, 2011-2016 |
Table 8 | Retail market scale of domestic yoghurt in China, 2010-2016 |
Table 9 | Retail market scale of domestic stirred yoghurt in China, 2010-2016 |
Table 10 | Retail market scale of domestic solidified yoghurt in China, 2010-2016 |
Table 11 | Standard for confected milk beverage and fermented milk beverage |
Table 12 | The economic indicators of milk beverages and plant protein beverages manufacturing in China, 2014-2016 |
Table 13 | The economic indicators of fruits and vegetables juice manufacturing in China, 2014-2016 |
Table 14 | The retail market scale of infant milk powder in China, 2011-2016 |
Table 15 | Market scale of cosmetics and growth rate of that in China, 2011-2016 |
Table 16 | Operating condition of Chr. Hansen, 2011-2016 |
Table 17 | Operating condition of Yakult, 2010-2016 |
Table 18 | Timetable of global distribution of Yakult |
Table 19 | Timetable of Yakult distribution in China |
Table 20 | Operating condition of DSM, 2011-2016 |
Table 21 | Brief introduction of DuPont probiotic products |
Table 22 | Probiotic products in Guangzhou Biostime |
Table 23 | Major economic indicators in Guangzhou Biostime, 2013-2016 |
Table 24 | Revenue of Guangzhou Biostime in terms of products, 2015-2016 |
Table 25 | Operating condition of Shanghai Jiaoda Onlly in terms of products in 2016 |
Table 26 | Revenue and profit statistics of Shanghai Jiaoda Onlly, 2012-2016 |
Table 27 | Operating condition of Shanghai Jiaoda Onlly in terms of regions in 2016 |
Table 28 | Main economic indicators of Kingworld Medicines Group, 2013-2016 |
Table 29 | Revenue in terms of products of Kingworld Medicines Group, 2015-2016 |
Table 30 | Revenue in terms of products of Sirio Pharma, 2012-2016 |
Table 31 | Revenue and profit statistics of Sirio Pharma, 2012-2016 |
Table 32 | Revenue in terms of regions of Sirio Pharma, 2012-2016 |
Table 33 | Basic information of Beijing Hanmi Pharmaceutical Co., Ltd |
Table 34 | Sales revenue and profit of Beijing Hanmi Pharmaceuticals, 2012-2016 |
Table 35 | Profitability indicators of Beijing Hanmi Pharmaceuticals, 2012-2016 |
Table 36 | Basic information of Hanchenshi (Shenyang) Children’s Products |
Table 37 | Probiotic products information of Hanchenshi (Shenyang) Children Products |
Table 38 | Total assets and total liabilities of Hanchenshi (Shenyang) Children Products, 2013-2016 |
Table 39 | Revenue and profit of Hanchenshi (Shenyang) Children Products, 2013-2015 |
Table 40 | Asset- liability ratio and profitability indicators of Hanchenshi (Shenyang) Children Products, 2013-2016 |
Table 41 | Sales revenue and total profit of Xiuzheng Pharmaceutical Group, 2012-2016 |
Table 42 | Profitability indicators of Xiuzheng Pharmaceutical Group, 2012-2016 |
Table 43 | Basic information of Hangzhou Minsheng Pharmaceutical Group |
Table 44 | Revenue and profit statistics of Hangzhou Minsheng Pharmaceutical Group, 2012-2016 |
Table 45 | Profitability indicators of Hangzhou Minsheng Pharmaceutical Group, 2012-2016 |
Table 46 | Basic information of Hutchison Healthcare Company |
Table 47 | Basic information of products of Hutchison Healthcare Company |
Table 48 | Basic information of PT Solution Biotechnology |
Table 49 | Probiotic products in PT Solution Biotechnology |
Table 50 | Major economic indicators in PT Solution Biotechnology in 2016 |
Table 51 | Basic information of Harbin Meihua Biotechnology |